Importer of Controlled Substances; Notice of Application, 69459-69460 [2010-28519]

Agencies

• Drug Enforcement Administration
• Department of Justice

[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Pages 69459-69460]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28519]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this 
is notice that on June 16, 2010, Cerilliant Corporation, 811 Paloma 
Drive, Suite A, Round Rock, Texas 78665-2402, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as an importer of the basic classes of controlled substances listed in 
schedule I and II:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).................................  I
Methcathinone (1237).............................  I
N-Ethylamphetamine (1475)........................  I
N,N-Dimethylamphetamine (1480)...................  I
Fenethylline (1503)..............................  I
Gamma Hydroxybutyric Acid (2010).................  I
Ibogaine (7260)..................................  I
Lysergic acid diethylamide (7315)................  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine       I
 (7348).
Marihuana (7360).................................  I
Tetrahydrocannabinols (7370).....................  I
Mescaline (7381).................................  I
3,4,5-Trimethoxyamphetamine (7390)...............  I
4-Bromo-2,5-dimethoxyamphetamine (7391)..........  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).......  I
4-Methyl-2,5-dimethoxyamphetamine (7395).........  I
2,5-Dimethoxyamphetamine (7396)..................  I
3,4-Methylenedioxyamphetamine (7400).............  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (7405).........  I
4-Methoxyamphetamine (7411)......................  I
Alpha-methyltryptamine (7432)....................  I
Diethyltryptamine (7434).........................  I
Dimethyltryptamine (7435)........................  I
Psilocybin (7437)................................  I
Psilocyn (7438)..................................  I

[[Page 69460]]

 
5-Methoxy-N,N-diisopropyltryptamine (7439).......  I
N-Benzylpiperazine (7493)........................  I
Etorphine (except HCl) (9056)....................  I
Heroin (9200)....................................  I
Morphine-N-oxide (9307)..........................  I
Normorphine (9313)...............................  I
Pholcodine (9314)................................  I
Dextromoramide (9613)............................  I
Dipipanone (9622)................................  I
Racemoramide (9645)..............................  I
Trimeperidine (9646).............................  I
Tilidine (9750)..................................  I
Amphetamine (1100)...............................  II
Methamphetamine (1105)...........................  II
Methylphenidate (1724)...........................  II
Amobarbital (2125)...............................  II
Pentobarbital (2270).............................  II
Secobarbital (2315)..............................  II
Phencyclidine (7471).............................  II
Phenylacetone (8501).............................  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Dihydrocodeine (9120)............................  II
Oxycodone (9143).................................  II
Hydromorphone (9150).............................  II
Benzoylecgonine (9180)...........................  II
Ethylmorphine (9190).............................  II
Meperidine (9230)................................  II
Methadone (9250).................................  II
Dextropropoxyphene, bulk (non-dosage forms)        II
 (9273).
Morphine (9300)..................................  II
Oripavine (9330).................................  II
Thebaine (9333)..................................  II
Levo-alphacetylmethadol (9648)...................  II
Oxymorphone (9652)...............................  II
Poppy Straw Concentrate (9670)...................  II
Fentanyl (9801)..................................
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances for the manufacture of analytical reference 
standards.
    No comments, objections, or requests for any hearings will be 
accepted on any application for registration or re-registration to 
import crude opium, poppy straw, concentrate of poppy straw, and coca 
leaves. As explained in the Correction to Notice of Application 
pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and 
requests for hearings on applications to import narcotic raw material 
are not appropriate.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances listed in schedule I or II, which fall under the authority 
of section 1002(a)(2)(B) of the Act [(21 U.S.C. 952 (a)(2)(B)] may, in 
the circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR Sec.  1301.43 and in such form as prescribed by 21 
CFR 1316.47.
    Any such comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than December 13, 2010.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, (40 FR 43745-46), all 
applicants for registration to import a basic class of any controlled 
substances in schedule I or II are, and will continue to be, required 
to demonstrate to the Deputy Assistant Administrator, Office of 
Diversion Control, Drug Enforcement Administration, that the 
requirements for such registration pursuant to 21 U.S.C. 958(a); 21 
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are 
satisfied.

     Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-28519 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P